AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PREOS Global Office Real Estate & Technology

Earnings Release Feb 16, 2021

5447_rns_2021-02-16_32021409-a4ca-49ec-bacd-520c534e0723.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Corporate | 16 February 2021 08:00

PREOS Global Office Real Estate & Technology AG again drives growth with 36.5% profit on sale of a 25,808 m² multi-tenant commercial property with a net rental area approx. 6,150 m² in Waltrop

DGAP-News: PREOS Global Office Real Estate & Technology AG / Key word(s): Disposal/Real Estate

16.02.2021 / 08:00

The issuer is solely responsible for the content of this announcement.

PREOS Global Office Real Estate & Technology AG again drives growth with 36.5% profit on sale of a 25,808 m² (277,795 sq. ft) multi-tenant commercial property with a net rental area approx. 6,150 m² (66,198 sq. ft) in Waltrop

Leipzig, 16 February 2021 – PREOS Global Office Real Estate & Technology AG (“PREOS”, ISIN DE000A2LQ850) this month, PREOS successfully closed the sale of a large commercial asset in Waltrop in Germany’s Ruhr region – Germany’s largest (and Europe’s sixth largest) aggregate network of urban communities with a population of approx. 5.1 million.

Despite risk-averse cautionary market conditions including COVID 19 disruption -in approx. 24 months since acquisition – the turnaround asset management model and execution skill set at PREOS delivered a high-value exit.

With spectacular acumen and precision, the PREOS asset management team successfully inked a 15-year lease extension with the building’s main tenant Nuvisan GmbH. Nuvisan GmbH is one of the largest pharmaceutical companies in Germany. Nuvisan provides pharmaceutical analysis for all molecules and antibodies and drug delivery formulation, works with Big Pharma customers and has further facilities in France. Besides Nuvisan, the tenant roster includes other well-known German companies such as Pharbil Waltrop GmbH, O+S Distelkamp GmbH and Chemische Werke Hommel.

The PREOS-Nuvisan GmbH transaction is regarded by market observers as further proof of PREOS’s excellence in strategy and execution at every stage of the value creation cycle: asset sourcing, tenancy/structural optimization and smooth and well-timed exit.

Press Contact:

Financial Press and Investor Relations:

edicto GmbH

Axel Mühlhaus

Phone: +49 69 905505-52

Mail: [email protected]

About PREOS Global Office Real Estate & Technology AG

PREOS Real Estate & Technology AG (“PREOS”) is an active real estate investor focused on office properties. PREOS acts as an efficient management holding company. The acquisition focuses on office properties with development potential in German metropolitan regions. Value creation is generated by targeted asset management measures. Developed portfolio properties are sold in the event of adequate sales opportunities. The corporate strategy is to significantly expand the real estate portfolio through acquisitions in the coming years. The PREOS share (ISIN DE000A2LQ850) is listed in the over-the-counter segment m:access of the Munich Stock Exchange (PAG.MU) and on Xetra (PAG.DE). The company headquarters of PREOS is located in Leipzig.


16.02.2021 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: PREOS Global Office Real Estate & Technology AG
Reichsstraße 2
04109 Leipzig
Germany
Phone: 0341 261787790
E-mail: [email protected]
Internet: www.preos.de
ISIN: DE000A2LQ850
WKN: A2LQ85
Listed: Regulated Unofficial Market in Frankfurt, Munich
EQS News ID: 1168495
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.